Welcome to Medications.com

Pacgen Reports Second Quarter Financial Results - Reuters

This study is a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. Nystatin is a widely used, ...

http://www.reuters.com/article/pr... | Posted: Wed Nov 28 22:26:52 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea